INTRAUTERINE GROWTH RESTRICTION IN PREGNANCY-INDUCED HYPERTENSION: INCIDENCE AND ASSOCIATED FACTORS IN A TERTIARY CARE SETTING OF KHYBER PAKHTUNKHWA, PAKISTAN

Incidence and associated factors of IUGR in pregnancy-induced hypertension women.

Authors

  • Uzma Bibi Department of Obstetrics and Gynaecology, King Abdullah Teaching Hospital Mansehra, Health Department KPK, Pakistan Author
  • Zarkaish Asmatullah Department of Obstetrics and Gynaecology, District Headquarters Hospital Battagram, Health Department KPK, Pakistan Author

Keywords:

pregnancy-induced hypertension, intrauterine growth restriction , gestational age , parity, weight

Abstract

Background: Pregnancy-induced hypertension (PIH) is one of the leading risk factors, commencing greater foetal and maternal morbidity and mortality worldwide. Among other complications, intrauterine growth restriction (IUGR) is a significant outcome of PIH. In the Pakistani context, the incidence of IUGR in PIH women and comparison with human factors is rarely determined. This study aimed to find the frequencies of IUGR among PIH women presenting to a tertiary care setup and determine the possible effect of age, gestation age, parity, and weight on IUGR. Methods: This cross-sectional study was conducted from 1st March to 30th August 2023 at the Department of Obstetrics and Gynaecology, Ayub Teaching Hospital, Abbottabad. The research comprised 159 pregnant women who had hypertension problems. The researcher underlined that all women underwent ultrasound biometry to determine IUGR per the Royal College of Obstetricians and Gynaecologists criteria. Results: Among the total 159 PIH women with a mean age of 27.691±2.63 years, the incidence of IUGR is 10.7%. IUGR was more prevalent in the 31–40 age group, i.e., 13%, having gestational age more than 30 weeks, i.e.16%, parity, i.e. 9.8%, and weight more than 70kg, i.e. 45.7%. Conclusion: The incidence of IUGR among women with PIH is low compared to neighbouring developing countries and requires individualized perinatal care, particularly among older aged, overweight, nulliparous, and beyond 30 weeks of gestation on a priority basis.

Downloads

Download data is not yet available.

Author Biographies

  • Uzma Bibi, Department of Obstetrics and Gynaecology, King Abdullah Teaching Hospital Mansehra, Health Department KPK, Pakistan

    Medical Officer MBBS, FCPS 

  • Zarkaish Asmatullah, Department of Obstetrics and Gynaecology, District Headquarters Hospital Battagram, Health Department KPK, Pakistan

    Medical Officer MBBS, FCPS

     

References

Luger RK, Kight BP. Hypertension in pregnancy. 2022 Oct. In: StatPearl [Internet] 2025. Treasure Island (FL): StatPearls Publishing; 2025.

Agarwal GS, Agrawal AK, Singhal D, Bawiskar D, Shedge SS. Pregnancy-induced hypertension pathophysiology and contemporary management strategies: A narrative review. Cureus 2024;16(7):e63961. DOI: https://doi.org/10.1002/hsr2.1274

Dapkekar P, Bhalerao A, Kawathalkar A, Vijay N. Risk factors associated with intrauterine growth restriction: A case-control study. Cureus 2023;15(6):e40178. DOI: https://doi.org/10.7759/cureus.40178

Dinu M, Stancioi-Cismaru AF, Gheonea M, Luciu ED, Aron RM, Pana RC, et al. Intrauterine growth restriction-prediction and peripartum data on hospital care. Medicina (Kaunas) 2023;59(4):773. DOI: https://doi.org/10.3390/medicina59040773.

Gordijn SJ, Beune IM, Thilaganathan B, Papageorghiou A, Baschat AA, Baker PN, et al. Consensus definition of foetal growth restriction: A Delphi procedure. Ultrasound Obstet. Gynecol. 2016;48:333–339.DOI: https://doi.org/10.1002/uog.15884.

Calek E, Binder J, Palmrich P, Eibensteiner F, Thajer A, Kainz T, et al. Effects of intrauterine growth restriction (IUGR) on growth and body composition compared to constitutionally small infants. Nutrients 2023;15(19):4158. DOI: https://doi.org/10.3390/nu15194158

Jabeen SS, Raoof M, Mumtaz F, Khan B, Shaheen Z. Intrauterine growth restriction among pregnant hypertensive women of urban and rural areas. Pak J Med Dent 2023;12(3):29–35. DOI: https://doi.org/10.36283/PJMD12-3/006

Barros FC, Barros AJ, Villar J, Matijasevich A, Domingues MR, Victora CG. How many low birthweight babies in low-and middle-income countries are pre-term? Rev Saude Publica 2011;45(3):607–16. DOI: https://doi.org/10.1590/S0034-89102011005000019

El-Baz MA, El-Deeb TS, El-Noweihi AM, Mohany KM, Shaaban OM, Abbas AM.. Environmental factors and apoptotic indices in patients with intrauterine growth retardation: a nested case-control study. Environ Toxicol Pharmacol 2015;39(2):589–96. DOI: https://doi.org/10.1016/j.etap.2015.01.009

Zafar H, Naz M, Fatima U, Irshad F. Frequency of IUGR in pregnancy induced hypertension. J Uni Med Dent Coll 2012;3(2):8–13.

Fox NS, Saltzman DH, Oppal S. The relationship between pre-eclampsia and intrauterine growth restriction in twin pregnancies. Am J Obstet Gynecol 2014;211(4):422.e1–5.

Almuhaytib FA, AlKishi NA, Alyousif ZM. Early Onset pre-eclampsia and intrauterine growth restriction: A case report. Cureus 2023;15(1):e33919. DOI: https://doi.org/10.7759/cureus.33919

Gudeta TA, Regassa TM. Pregnancy induced hypertension and associated factors among women attending delivery service at Mizan-Tepi University Teaching Hospital, Tepi General Hospital and Gebretsadik Shawo Hospital, Southwest, Ethiopia. Ethiop J Health Sci 2019;29(1):831–40. DOI: https://doi.org/10.4314/ejhs.v29i1.4

Majeed S, Khawaja A, Tunio NA, Unar F, Khan FA. To determine frequency of intrauterine growth restriction in pregnancy induced hypertension. Pak J Med Health Sci 2020;14(2):240–2.

Febrina NAD, Primadi A, Lestari BW. Association between intrauterine growth restriction and pregnancy hypertension. Althea Med J 2016;3(2):212–5. DOI: https://doi.org/10.1186/s12889-019-7973-9

Dumolt JH, Powell TL, Jansson T. placental function and the development of foetal overgrowth and foetal growth restriction. Obstet Gynecol Clin North Am 2021;48(2):247–66. DOI: https://doi.org/10.1016/j.ogc.2021.02.001

Napso T, Lean SC, Lu M, Mort EJ, Desforges M, Moghimi A, et al. Diet-induced maternal obesity impacts feto-placental growth and induces sex-specific alterations in placental morphology, mitochondrial bioenergetics, dynamics, lipid metabolism and oxidative stress in mice. Acta Physiol (Oxf) 2022;234(4):e13795. DOI: https://doi.org/10.1111/apha.13795

Qamar MK, Khan YQ, Irum N, Manzppr S. Frequency of intrauterine growth retardation in obese pregnant females: A cross sectional study in two tertiary care hospitals of Pakistan. J Soc Obstet Gynaecol Pak 2021;11(4):246–9.

Inaugural issue

Downloads

Published

05/19/2025

Data Availability Statement

The datasets used and/or analyzed during the current study are available from the corresponding author on request

Issue

Vol. 1 No. 1 (2025): The Genesis of MedPulse: Pioneering Research and Clinical Excellence

Section

Original Articles

License

Copyright (c) 2025 MedPulse Spectrum

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

  1. Grant of License: By submitting content (including but not limited to articles, manuscripts, and multimedia) to MedPulse Spectrum Journal, you grant us a non-exclusive, worldwide, royalty-free license to reproduce, distribute, publicly display, and perform the submitted content for the purpose of publishing, promoting, and improving the Journal.

  2. Copyright Ownership: Authors retain the copyright to their work published in MedPulse Spectrum Journal. We request, however, an exclusive license to be the first to publish the work, after which the authors are free to republish, reproduce, or distribute their content with proper acknowledgment of its initial publication in MedPulse Spectrum Journal.

  3. Attribution: Authors agree that their submitted content will be appropriately attributed to them in connection with its use by MedPulse Spectrum Journal.

  4. Permissions: Authors are responsible for obtaining any necessary permissions for the use of third-party materials included in their submissions and must provide evidence of such permissions upon request.

  5. Modification and Removal: MedPulse Spectrum Journal reserves the right to make necessary editorial modifications to submitted content for clarity, consistency, and adherence to journal standards. Authors can request content removal, subject to the Journal's discretion, recognizing that previous versions may persist in the Journal's archives.

  6. Non-Commercial Use: The use of content from MedPulse Spectrum Journal is intended for non-commercial purposes. Any commercial use requires explicit written permission from the Journal.

By submitting content to MedPulse Spectrum Journal, you acknowledge and agree to these licensing terms. The Journal reserves the right to update these terms periodically.

How to Cite

INTRAUTERINE GROWTH RESTRICTION IN PREGNANCY-INDUCED HYPERTENSION: INCIDENCE AND ASSOCIATED FACTORS IN A TERTIARY CARE SETTING OF KHYBER PAKHTUNKHWA, PAKISTAN: Incidence and associated factors of IUGR in pregnancy-induced hypertension women. (2025). MedPulse Spectrum, 1(1), 23-26. https://jouex.com/index.php/medpulspect/article/view/18

Similar Articles

You may also start an advanced similarity search for this article.